Tioga Pharmaceuticals
Tioga Pharmaceuticals, Inc. develops therapies for the treatment of gastrointestinal diseases. Its product includes asimadoline, an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional...Founded in 2005
Homepage: http://www.tiogapharma.com/
Total money raised: $52M
92121
9393 Towne Centre Drive
Suite 200
San Diego
USA CA
Suite 200
San Diego
USA CA
Phone: 858-677-6077
Updated on Apr 12, 2012
Tioga Pharmaceuticals at CrunchBase
Stuart J. M. Collinson CEOTioga Pharmaceuticals at CrunchBase
David Urso COO
Past
April, 2012
Tioga Pharmaceuticals raised $10M in a Series B round from Thomas, McNerney & Partners and Genesys Capital
Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome 
tiogapharma.com
February, 2010
Tioga Pharmaceuticals raised $18M in a Series A round from Forward Ventures, New Leaf Venture Partners, BB Biotech Ventures, and Genesys Capital
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome tiogapharma.com
January, 2006
Tioga Pharmaceuticals raised $24M in a Series A round from Forward Ventures, New Leaf Venture Partners, and BB Biotech Ventures
Tiogas Series A Round: $24M For Phase IIb Trial Of IBS Drug tiogapharma.com
2005
Tioga Pharmaceuticals was founded in 2005